LATAM Pharmacovigilance Specialist AE Reporting & Compliance

IQVIA; Santiago; Vor Ort; CLP 14.000.000 - 21.000.000; Vollzeit

Zusammenfassung

IQVIA is seeking a Pharmacovigilance Analyst to support LATAM safety activities across client projects. The role includes AE identification, data source review, and timely reporting in line with local requirements and PV standards.

You will contribute to PV documentation, audits, and process improvements while collaborating with PMR, CES, and client teams. A life sciences degree and 2–4 years of PV experience are expected.

Qualifikationen

• Bachelor's Degree in Life Sciences or related field required.
• 2–4 years of pharmacovigilance or lifecycle safety experience.
• Strong understanding of adverse event reporting timelines and safety concepts.

Aufgaben

• Identify adverse events and review data sources across client projects.
• Ensure timely AE reporting to clients per timelines and local requirements.
• Support PV documentation, trackers, procedures, and reporting specs.
• Perform qualitative review of safety information for completeness and accuracy.
• Contribute to client deliverables including AE reports and safety process docs.
• Collaborate with cross-functional teams to ensure safety oversight.
• Provide training to junior analysts on AE identification and reporting requirements.

Kenntnisse

Adverse event identification

Pharmacovigilance concepts

Data review and reporting

Analytical thinking

Time management

Communication skills

Ausbildung

Bachelor's degree in Life Sciences or related field

Tools

Regulatory databases

Jobbeschreibung

IQVIA is seeking a Pharmacovigilance Analyst to support LATAM safety activities across client projects. The role includes AE identification, data source review, and timely reporting in line with local requirements and PV standards.

You will contribute to PV documentation, audits, and process improvements while collaborating with PMR, CES, and client teams. A life sciences degree and 2–4 years of PV experience are expected.